Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures
ConclusionsFuture research is needed to investigate whether the wide variability in reporting rates for severe HSRs associated with these intravenous iron products are due to potential differences in the safety profiles of these substances.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Anaphylactic Shock | Databases & Libraries | Drugs & Pharmacology | European Medicines Agency (EMA) | Iron | Study